학술논문

Suppression of KRAS and CBL Mutations and Hematological Improvement By Lenzilumab and Azacitidine Treatment in Proliferative Chronic Myelomonocytic
Document Type
Journal
Source
BLOOD; NOV 2 2023, 142 4p. Supplement: 1
Subject
Language
English
ISSN
15280020